Praxsyn Announces Completion of OTCQB Application

IRVINE, Calif., June 18, 2015 -- Praxsyn Corporation (OTCQB:PXYN) is pleased to announce their compliance with the new OTC standards, allowing the company to remain on the OTCQB tier. The new procedures for being on the OTCQB tier included an application process with a fee. Praxsyn is pleased to report that they have completed the application process and have paid the required fee.

Praxsyn Announces New Service Agreement with NHS Pharma

IRVINE, Calif., June 15, 2015 -- Praxsyn Corporation’s (OTCQB:PXYN) wholly owned subsidiary, Mesa Pharmacy Inc. (Mesa), announced today that on June 9, 2015, it executed a new Services Agreement with NHS Pharma Sales, Inc. (NHS). Through its relationship with NHS, Mesa’s revenue has grown significantly over the past six months. NHS is building on its mutually beneficial relationship and taking on a more active role in its affiliation with Mesa.

Praxsyn's 2015 Anticipated Business Strategies

IRVINE, Calif., June 8, 2015 -- Praxsyn Corporation's (OTCQB:PXYN) anticipated business plan for 2015 is to acquire a sister subsidiary retail community pharmacy and to purchase additional pharmacies. Mesa is also in the early stages of developing a program to supply medications and products to diabetic patients and anticipates the commencement of filling prescriptions by the end of the third quarter of 2015. 

Praxsyn Announces New Business Associate Agreement with Products for Doctors

IRVINE, Calif., April 13, 2015 -- Praxsyn Corporation’s (OTCQB:PXYN) wholly owned subsidiary, Mesa Pharmacy Inc. (Mesa), entered into a Business Associate Agreement with Products for Doctors for marketing and other services on January 23, 2015. The non-exclusive agreement between Products for Doctors and Mesa facilitates the marketing of Mesa’s products to medical providers throughout California.